Skip to main content
Year archive

Synbiotic SE — 2024 filings

All 37 regulatory filings released by Synbiotic SE (SBX) in 2024, sourced directly from the official regulator.

37 Filings
2024 Period
2024 filings (37)
Filing Released Lang
Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis
Regulatory Filings
2024-12-19 English
Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis
Regulatory Filings
2024-12-18 English
SYNBIOTIC SE geht mit der GOC NEXUS OPERATIONS GMBH strategische Partnerschaft ein.
Capital/Financing Update
2024-12-14 German
SYNBIOTIC SE: Einbringung der CannaCare Health GmbH wird nicht durchgefuhrt.
Regulatory Filings
2024-12-13 German
SYNBIOTIC SE: Einbringung der CannaCare Health GmbH wird nicht durchgefuhrt.
M&A Activity
2024-12-12 German
Corporate Presentations ENG
Investor Presentation
2024-11-30 English
Corporate Presentations ENG
Investor Presentation
2024-11-30 English
SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry
M&A Activity
2024-11-25 English
SynBiotic SE schliet Einbringungsvertrag uber den Erwerb von 50,2 % der Anteile an der greensby UG (haftungsbeschrankt), Vettweiss, ab.
Regulatory Filings
2024-11-23 German
SynBiotic SE schliet Einbringungsvertrag uber den Erwerb von 50,2 % der Anteile an der greensby UG (haftungsbeschrankt), Vettweiss, ab.
M&A Activity
2024-11-22 German
SYNBIOTIC SE: Frank Otto, Erwerb von Aktien durch Ausubung von Wandlungsrechten aus Wandelschuldverschreibung (ISIN DE000A351VJ4)
Director's Dealing
2024-11-13 German
Company agreement - Satzung - SYNBIOTIC SE
Governance Information
2024-11-04 German
SynBiotic SE - Half-year report 2023 HGB (DE | PDF)
Interim / Quarterly Report H1 2023
2024-09-28 German
Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval
AGM Information
2024-09-27 English
SynBiotic SE - Half-year report 2024 HGB (DE | PDF)
Interim / Quarterly Report H1 2024
2024-09-27 German
SYNBIOTIC SE: Begebung einer Wandelanleihe von bis zu EUR 300.000,00 unter Ausschluss des Bezugsrechts beschlossen.
Capital/Financing Update
2024-08-30 German
SYNBIOTIC Annual General Meeting on 20.09.2024: Increasing sales drive growth
AGM Information
2024-08-16 English
SynBiotic SE erwartet deutliches Umsatzwachstum fur das Geschaftsjahr 2024
Earnings Release FY 2024
2024-08-16 German
SynBiotic SE - Annual Report IFRS 2023  (DE | PDF)
Annual Report FY 2023
2024-08-07 German
SynBiotic SE - Individual Financial Statement 2023 HGB (DE | PDF)
Audit Report / Information FY 2023
2024-08-05 German
SYNBIOTIC SE: Frank Otto, Ubertragung von 10.500 Aktien an einen Glaubiger zum Ausgleich einer Gesamtforderung in Hohe von EUR 74.030,17. Der Glaubiger beabsichtigt, die Aktien nach der ...
Director's Dealing
2024-06-03 German
Berlin, Prague, Berlin: SYNBIOTIC and CEO Daniel Kruse on roadshow
Regulatory Filings
2024-05-23 English
Acquisition of WEECO Pharma: SYNBIOTIC significantly expands its position in the medical cannabis market
M&A Activity
2024-05-08 English
SynBiotic SE schliet Einbringungsvertrag uber den Erwerb aller Anteile an der WEECO Pharma GmbH, Hildesheim ab
M&A Activity
2024-05-07 German
1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project (news with additional features)
Regulatory Filings
2024-04-25 English
SYNBIOTIC acquires Ilesol: Enormous competitive advantages through cannabinoid extracts and isolates from own production
M&A Activity
2024-04-23 English
SynBiotic SE schliet Einbringungsvertrag uber den Erwerb aller Anteile an der Ilesol Pharmaceuticals d.o.o. (Kroatien)
Share Issue/Capital Change
2024-04-19 German
SYNBIOTIC SE: Nach Teil-Legalisierung: Bushdoctor meldet starkes Auftragsplus aus Deutschland
Earnings Release Q4 2023
2024-04-12 German
SynBiotic SE: Deutschlands fuhrende Cannabis-Unternehmensgruppe nimmt Stellung zur Bundesratsentscheidung zum Cannabisgesetz
Regulatory Filings
2024-03-22 German
SynBiotic SE: Frank Otto, Granting of 86,465 subscription rights as part of the rights issue of a 6% convertible bond March 2024/2025.
Share Issue/Capital Change
2024-03-19 English
SynBiotic SE: Frank Otto, Granting of 86,465 subscription rights as part of the rights issue of a 6% convertible bond March 2024/2025.
Director's Dealing
2024-03-15 English
SynBiotic SE: HempConsult GmbH, Granting of 422,100 subscription rights as part of the issue of a convertible bond.
Director's Dealing
2024-03-14 English
SynBiotic SE: Daniel Kruse, Granting of 4,600 subscription rights as part of the issue of a convertible bond.
Director's Dealing
2024-03-14 English
SynBiotic SE: Frank Otto, Transfer of 12,000 shares as part of an equalisation agreement on claims under the law of obligations.
Director's Dealing
2024-03-14 English
SynBiotic SE: Cannabis-Teillegalisierung offnet fur SynBiotic SE neue Ara des Wachstums
Share Issue/Capital Change
2024-03-01 German
SynBiotic SE: Korrektur der Veroffentlichung vom 29.02.2024, 16:00 Uhr CET/CEST
Share Issue/Capital Change
2024-02-29 German
SynBiotic SE: Erfolgreicher Abschluss einer Kapitalerhohung (Vollplatzierung) sowie der Begebung einer Wandelschuldverschreibung
Share Issue/Capital Change
2024-02-29 German